Drug Targets Flashcards

1
Q

“EMPIRICAL’ Drug-Discovery

A
  • Recognize initial drug lead by functionally useful effect
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Examples of empirical drug discovery

A
  • Penicillin (anti-bacterial effect);
  • Taxol (anti-tumor)
  • Digoxin (cardiotonic / antiarrythmic)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

“RATIONAL Drug discovery

A
  • Drug by design or screen against biochemical target’s function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Examples of rational drug discovery

A
  • HIV-protease inhibitor (anti-infection)
  • Metoprolol (anti-hypertensive)
  • Methotrexate (anti-tumour)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Major causes of Drug Failure in Phase II

A

• Wrong target?
• Wrong patient population?
• Wrong dose?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a Drug Target?

A

A bio-molecule which either:
– Is present in the diseased tissue
– Has elevated expression in the diseased tissue
– Is overactive in diseased tissue
– Has a function contributing to development or existence of disease
– Has an involvement or role in disease process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Drug Targets and Mechanisms

A
  • Enzymes Reversible = Irreversible Inhibitors
    • Receptors = Agonists & Antagonists
    • Viral Surface Proteins = Block entry into cell
    • Ion channels = Block or Open channel
    • Transporters = Block or promote transport
    • Nucleic Acids = Inhibit function, prevent gene expression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Targets for Drug Action

A
  • look at slide 10
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What factors must pharmaceutical companies consider when developing drugs?

A

• Both economic and medical factors.
• They must ensure a financial return on investment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What caused a rise in antimalarial research by pharmaceutical companies?

A

• Growth in tourism to exotic countries.
• The spread of malaria to regions affecting wealthier populations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why do pharmaceutical companies focus on diseases with few treatment options?

A

• To address unmet medical needs.
• To create drugs with better properties than existing ones.
• Ensures competitive advantage in the market.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What makes a good target?

A
  • Must be differentially expressed / regulated/ located in diseased tissue
    • Must be central to disease process with robust studies in clinical samples
    • Must be characterised in terms of expression, activity, function and role
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why does disease-association not make a protein a viable drug target?

A
  • The protein must be validated as a point of intervention in the disease pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What roles do bioinformatics and cheminformatics play in drug discovery?

A

• Bioinformatics: Identifies and analyzes disease-related targets using biological data.
• Cheminformatics: Helps design and optimize drug-like molecules by analyzing chemical data.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Target Validation Process

A
  • Disease
  • Target
  • Target Selection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug Discovery Process

A
  • Target Selection
  • Leads
  • Clinic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Target Validation

A
  • Identifies and assesses whether a molecular target merits the development of drugs
  • process of demonstrating that a molecular target is a therapeutically relevant pharmacological target
18
Q

What is the most important part of drug discovery ?

A
  • Target validation
19
Q

A Valid Target is:

A
  • A target that when modulated pharmacologically, provides meaningful efficacy and acceptable safety for specific human disease in long-term clinical usage
20
Q

Target Validation is:

A
  • The process of demonstrating that engaging the target provides statistically meaningful therapeutic benefit with acceptable safety for a given indication.
21
Q

Proof of Concept is:

A
  • Preclinical or limited clinical studies prior to well-powered clinical trials, that establish the scientific validity and safety of a drug target; it is part of the
    continuum of target validation.
22
Q

Target Identification is:

A
  • The generation of scientific evidence that a manipulatable able target is involved in some significant way in a disease process
23
Q

What is the purpose of target validation?

A
  • Increases our confidence in the relationship between the target and the disease.
  • Demonstrates target is critical or central to disease development or progression.
  • Allows exploration of effects caused by modulation of target, to identify mechanism based adverse effects
24
Q

Target validation of human data

A
  • clinical experience (most important)
  • genetics
  • tissue expression
25
Target qualification of preclinical data
- translational endpoints (most important) - genetically engineered models - pharmacology
26
Target expression relationship
Slide 20
27
Genetic relationship to disease
Slide 21
28
Clinical trial data and validation
Slide 22
29
Preclinical pharmacological validation
Slide 23
30
Preclinical genetic validation
Slide 24
31
Clinical translatability of preclinical data
Side 25
32
How do you identify the target?
- Genomics - proteonomics - gene association
33
How can genetics help identify a valid target?
• the study of SNPs (single nucleotide polymorphisms) and polymorphisms that link genetic variations to disease.
34
How are in vitro models used to validate a target?
- Techniques like siRNA
35
How are in vitro models used to validate a target?
- Techniques like siRNA
36
What role does clinical data play in target validation?
- disease database
37
How do expression patterns contribute to target validation?
- Location, Disease modulation, Microarray studies
38
How are in vivo models used to validate a target?
- Transgenic, Null / Knock-out mice, Behavioural models
39
What is the role of model organisms in target validation?
- Organisms like Drosophila, zebrafish, and C. elegans are used to study the biological roles of targets in simpler systems.
40
How do ‘omics’ technologies assist in target identification?
- fields like genomics, proteomics, and transcriptomics provide large-scale data on gene, protein, and transcript interactions with disease
41
Identifying the actual drug target
- detection of ‘new’ drug target in samples of diseased tissue - compare expression of ‘new drug targets in many clinical samples - creation of a test model